|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
EP1883302A4
(en)
*
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
|
WO2008009458A1
(en)
|
2006-07-21 |
2008-01-24 |
Novartis Ag |
2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
|
|
SG165655A1
(en)
|
2008-04-16 |
2010-11-29 |
Portola Pharm Inc |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
HRP20161310T1
(hr)
|
2008-04-16 |
2016-12-02 |
Portola Pharmaceuticals, Inc. |
2,6-diamino-pirimidin-5-il-karboksamidi kao inhibitori syk ili jak kinaza
|
|
US9139534B2
(en)
|
2011-04-22 |
2015-09-22 |
Signal Pharmaceuticals, Llc |
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
|
|
CN104159891B
(zh)
|
2012-01-10 |
2016-09-07 |
霍夫曼-拉罗奇有限公司 |
哒嗪酰胺化合物和它们作为syk 抑制剂的用途
|
|
UY34807A
(es)
|
2012-05-16 |
2013-12-31 |
Novartis Ag |
Derivados monocíclicos de heteroarilcicloalquil- diamina
|
|
US9040530B2
(en)
|
2012-06-22 |
2015-05-26 |
Portola Pharmaceuticals, Inc. |
1,2,4-triazine-6-carboxamide kinase inhibitors
|
|
LT3495358T
(lt)
|
2012-11-08 |
2022-05-25 |
Bristol-Myers Squibb Company |
Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai
|
|
KR102233252B1
(ko)
|
2012-11-08 |
2021-03-26 |
브리스톨-마이어스 스큅 컴퍼니 |
ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물
|
|
JP2014198693A
(ja)
|
2013-03-29 |
2014-10-23 |
大鵬薬品工業株式会社 |
免疫疾患の予防及び／又は治療剤
|
|
TWI582077B
(zh)
|
2013-11-07 |
2017-05-11 |
必治妥美雅史谷比公司 |
作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物
|
|
GB201717260D0
(en)
|
2017-10-20 |
2017-12-06 |
Galapagos Nv |
Novel compounds and pharma ceutical compositions thereof for the treatment of inflammatory disorders
|
|
EA202091269A1
(ru)
|
2017-11-21 |
2020-08-07 |
Бристол-Маерс Сквибб Компани |
Сульфон-, пиридин-, алкил-, амид-замещенные гетероарильные соединения
|
|
CN111936486B
(zh)
*
|
2018-03-22 |
2023-09-22 |
百时美施贵宝公司 |
用作IL-12、IL-23和/或IFNα响应的调节剂的包含吡啶的杂环化合物
|
|
JP7631193B2
(ja)
*
|
2018-10-22 |
2025-02-18 |
アルミス インコーポレイテッド |
Ｔｙｋ２阻害剤およびその使用
|
|
AU2019373203B2
(en)
|
2018-10-30 |
2024-10-24 |
Bristol-Myers Squibb Company |
Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
|
|
CN115448910B
(zh)
*
|
2019-01-28 |
2024-04-19 |
江苏豪森药业集团有限公司 |
一种哒嗪类衍生物抑制剂、其制备方法和应用
|
|
CN111484480B
(zh)
*
|
2019-01-29 |
2023-08-11 |
上海翰森生物医药科技有限公司 |
一种多环类衍生物抑制剂、其制备方法和应用
|
|
US20230093099A1
(en)
*
|
2019-04-02 |
2023-03-23 |
Cullgen (Shanghai), Inc. |
Compounds and methods of treating cancers
|
|
CN114787154A
(zh)
*
|
2020-01-19 |
2022-07-22 |
苏州科睿思制药有限公司 |
一种Deucravacitinib的晶型及其制备方法和用途
|
|
SMT202400185T1
(it)
*
|
2020-03-11 |
2024-07-09 |
Beijing Innocare Pharma Tech Co Ltd |
Composti eterociclici per inibire attività di tyk2
|
|
WO2021202652A1
(en)
*
|
2020-04-01 |
2021-10-07 |
Eternity Bioscience Inc. |
Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereof
|
|
AU2021254764A1
(en)
*
|
2020-04-14 |
2022-11-03 |
Gossamer Bio Services, Inc. |
Substituted pyridines for the treatment of inflammatory diseases
|
|
CN113563309B
(zh)
*
|
2020-04-28 |
2024-12-13 |
浙江海正药业股份有限公司 |
吡啶类衍生物及其制备方法和用途
|
|
US20220002267A1
(en)
|
2020-06-24 |
2022-01-06 |
Eternity Bioscience Inc. |
Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereof
|
|
CN113968846A
(zh)
|
2020-07-24 |
2022-01-25 |
上海翰森生物医药科技有限公司 |
一种哒嗪类衍生物的盐、晶型及其制备方法和应用
|
|
WO2022117016A1
(zh)
*
|
2020-12-02 |
2022-06-09 |
深圳微芯生物科技股份有限公司 |
羟肟酸酯化合物、其制备方法及其应用
|
|
CN115197196B
(zh)
*
|
2021-04-06 |
2024-06-18 |
扬子江药业集团有限公司 |
Tyk2抑制剂及其用途
|
|
TWI804266B
(zh)
*
|
2021-04-07 |
2023-06-01 |
大陸商上海齊魯製藥研究中心有限公司 |
Tyk2抑制劑及其用途
|
|
US12509360B2
(en)
|
2021-04-16 |
2025-12-30 |
Sri Lanka Institute Of Information Technology |
Method of making silver-iron titanate nanoparticles and uses thereof
|
|
CN115466257A
(zh)
*
|
2021-06-11 |
2022-12-13 |
爱科诺生物医药(香港)有限公司 |
具有tyk2抑制活性的化合物，包含其的药物组合物，及其应用
|